Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large & Mid Cap Fund median (36 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 26 Feb 2015 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | LIC MF Large & Mid Cap Fund |
|---|---|
| 26 Feb 2015 | ₹100.00 |
| 10 Feb 2016 | ₹87.95 |
| 25 Jan 2017 | ₹118.23 |
| 09 Jan 2018 | ₹160.65 |
| 25 Dec 2018 | ₹149.49 |
| 09 Dec 2019 | ₹167.90 |
| 23 Nov 2020 | ₹185.08 |
| 07 Nov 2021 | ₹270.23 |
| 22 Oct 2022 | ₹273.11 |
| 07 Oct 2023 | ₹306.84 |
| 20 Sep 2024 | ₹458.27 |
| 05 Sep 2025 | ₹437.82 |
| 20 Aug 2026 | ₹463.13 |
| Metric | LIC · Direct NAV ₹46.38 Very High risk ★★☆☆☆ | Category median Large & Mid Cap Fund · 36 funds |
|---|---|---|
| +4.36% | +6.71% | |
| +16.44% | +16.28% | |
| +13.62% | +15.15% | |
| +15.32% | +15.07% | |
| +14.28% | +15.33% | |
| +13.23% | — | |
| +16.37% | +17.48% | |
| +16.40% | +16.77% | |
| +16.19% | +16.31% | |
| Risk | ||
| 15.57% | 14.81% | |
| 0.64 | 0.61 | |
| 0.87 | 0.82 | |
| -33.92% | -35.67% | |
| Nifty Midcap 150 | — | |
| -0.18% | +0.30% | |
| 0.90 | 0.83 | |
| 91.5% | 84.1% | |
| 90.6% | 78.7% | |
| 1.67% | 1.07% | |
| ₹3,133Cr | ₹3,576Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹200 | — | |
| ₹5.00K | — | |
| 39% | 42% | |
| Yogesh Patil | — | |
| 26 Feb 2015 | — | |
| 42 | — | |
| 33.3% | — | |
| 1.5% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.